URL | Priority | Change frequency | Last modified (GMT) |
---|---|---|---|
https://www.clinicaltrialsarena.com/contractors/data/akero-efruxifermin-ozempic-nash-phase-ii-cohort-data/pressreleases/press2-18/ | 100% | Daily | 2019-07-29 12:14 |
https://www.clinicaltrialsarena.com/contractors/data/akero-efruxifermin-ozempic-nash-phase-ii-cohort-data/pressreleases/press2-13/ | 100% | Daily | 2019-07-29 12:14 |
https://www.clinicaltrialsarena.com/contractors/data/akero-efruxifermin-ozempic-nash-phase-ii-cohort-data/pressreleases/press1-21/ | 100% | Daily | 2019-07-29 12:14 |
https://www.clinicaltrialsarena.com/contractors/data/akero-efruxifermin-ozempic-nash-phase-ii-cohort-data/pressreleases/press2-15/ | 100% | Daily | 2019-07-29 12:14 |
https://www.clinicaltrialsarena.com/contractors/data/akero-efruxifermin-ozempic-nash-phase-ii-cohort-data/pressreleases/press1-22/ | 100% | Daily | 2019-07-29 12:14 |
https://www.clinicaltrialsarena.com/contractors/data/akero-efruxifermin-ozempic-nash-phase-ii-cohort-data/pressreleases/press6-5/ | 100% | Daily | 2019-07-29 12:14 |